Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system. The longer Esprit BTK system received approval for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD). CLTI can cause extreme pain, open wounds that don’t heal and, in some cases, […]
Abbott
AtaCor treats first patient in EV-ICD lead study in partnership with Abbott
AtaCor Medical announced today that it enrolled the first patient in its ALARION-EV extravascular implantable cardioverter-defibrillator (EV-ICD) trial. ALARION-EV evaluates a next-generation parasternal EV-ICD system. It features AtaCor’s Atala lead in combination with an EV-ICD pulse generator developed by Abbott. The study evaluates the system in patients indicated for a standard ICD but do not […]
Tandem Diabetes Care launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in new geographies
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched the t:slim X2 insulin pump with the Abbott FreeStyle Libre 3 Plus in five new countries. San Diego-based Tandem launched the pairing of its flagship automated insulin delivery system with Control-IQ+ technology with Abbott’s latest continuous glucose monitor (CGM) sensor in the U.S. in October 2025. […]
Abbott data backs TriClip, Navitor, next-gen Amulet systems
Abbott (NYSE:ABT) today shared new findings supporting its TriClip, Navitor and investigational Amulet 360 systems. The medtech giant shared its findings at New York Valves 2026: The Structural Heart Summit, in multiple presentations. Abbott’s TriClip transcatheter edge-to-edge repair (TEER) offers an option for those who aren’t good candidates for surgery and continue to have symptoms or […]
CMS proposes TAVR coverage update that benefits Edwards, Medtronic, Abbott
The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed an update to its coverage for transcatheter aortic valve replacement (TAVR) therapy. CMS proposed an update to its National Coverage Determination (NCD), having initiated a review in December 2025 after accepting a request from TAVR leader Edwards Lifesciences for an NCD update. The proposal, […]
The biggest diabetes tech news out of ADA 2026
The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation automated insulin delivery platforms, continuous glucose monitors (CGMs) and all kinds of other technologies were on display in New Orleans. BTIG analysts Marie Thibault, Alexandra Pang and Sam Eiber […]
Abbott launches next-gen CardioMEMS Hero pulmonary artery pressure reader in US
Abbott (NYSE:ABT) said today that it launched its CardioMEMS HERO Device, a next-generation pulmonary artery (PA) pressure reader in the U.S. In a LinkedIn post, the medtech giant wrote: “Our CardioMEMS HERO Device is now available in the U.S. With simple setup and easy connection, this smaller and lighter patient reader is designed to support […]
Insulet launches enhanced Omnipod 5 algorithm, expands Abbott compatibility
Insulet (Nasdaq:PODD) announced today that it is rolling out new algorithm enhancements for its Omnipod 5 automated insulin delivery system. The company also expanded its compatibility with Abbott sensors, adding the option of pairing Omnipod 5 with FreeStyle Libre 3 Plus. Acton, Massachusetts-based Insulet won FDA clearance for its algorithm enhancements in December 2025. The […]
MiniMed adds Abbott dual glucose-ketone sensor to portfolio, posts Q4 sales beat
MiniMed (Nasdaq:MMED) announced today that it expanded its agreement with Abbott (NYSE:ABT) to add more sensors to its portfolio. The company also announced fourth-quarter earnings results in tandem with the new Abbott integration. MiniMed has an existing partnership with Abbott through a collaboration between the companies agreed in 2024. They integrated Instinct, a sensor made by […]
Abbott wins CE mark for dual glucose-ketone sensor
Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people with diabetes. The company said its dual sensor marks a world first, continuously measuring glucose and ketone levels every minute. Branded as Libre Duo and Libre Duo 10 Day, the sensors provide real-time visibility into glucose levels […]
The top stories from EuroPCR 2026
EuroPCR 2026 brought together a range of treatment developers across interventional cardiology in Paris last week. Technologies on display included intravascular lithotripsy (IVL) systems, transcatheter heart valves, renal denervation (RDN) technologies, drug-eluting stents and more. Usual big names in the cardiovascular space like Medtronic, Boston Scientific and Abbott shared updates. Meanwhile, innovators like Jupiter Neurovascular, […]
